Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Investigating Ribosome-Targeting Therapies for the Treatment of Relapsed/Refractory Multiple Myeloma — Kezia Gitareja (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Investigating Ribosome-Targeting Therapies for the Treatment of Relapsed/Refractory Multiple Myeloma
Shared by
Elaine Sanij
St. Vincent’s Institute of Medical Research
Investigating Ribosome-Targeting Therapies for the Treatment of Relapsed/Refractory Multiple Myeloma
Article
2025
en
Authors
+4 more
KG
Kezia Gitareja
KM
Kylee Maclachlan
Amit Khot
University of Melbourne
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2010
Emerging therapies for the treatment of relapsed or refractory multiple myeloma
Meletios A Dimopoulos
,
Jesús F. San Miguel
,
Kenneth C. Anderson
Article
2009
Treatment of Relapsed/Refractory Multiple Myeloma
Efstathios Kastritis
,
Antonio Palumbo
,
Meletios A Dimopoulos
Article
2015
Treatment options for relapsed and refractory multiple myeloma
Ajay K. Nooka
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Sagar Lonial
Chapter in a book
2017
Treatment of Relapsed/Refractory Patients with Multiple Myeloma
Jacob P. Laubach
,
Philippe Moreau
,
Meletios A Dimopoulos
,
Paul G. Richardson
Article
2024
Targeting the ribosome to treat multiple myeloma
Kylee Maclachlan
,
Kezia Gitareja
,
Jian Jian Kang
,
Andrew Cuddihy
,
Yuxi Cao
,
Nadine Hein
,
Carleen Cullinane
,
Ching‐Seng Ang
,
Natalie Brajanovski
,
Richard B. Pearson
,
Amit Khot
,
Elaine Sanij
,
Ross D. Hannan
,
Gretchen Poortinga
,
Simon J. Harrison
Discussion(0)
No comments yet. Be the first to comment.